Abstract:Transcriptional pausing is a widely used regulatory mechanism to control precise gene expression from bacteria to humans. In metazoans, transcription initiation requires the recruitment of general transcription factors and RNA polymerase II (Pol II) to gene promoters. After it initiates transcription and synthesizes a short RNA, Pol II pauses at the promoter-proximal region, standing by for further cues to enter the productive elongation stage. Promoter-proximal Pol II pausing is one of the rate-limiting steps during transcription, functioning as an early transcriptional elongation check point, to ensure the correct modification of transcription machinery and the addition of the 7-methylguanosine cap to nascent transcripts. Pol II pausing at promoter-proximal region is stabilized by the negative elongation factor (NELF) and the 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole (DRB) sensitivity-inducing factor (DST). In response to developmental signals or environmental stress, the release of paused Pol II can be triggered by the positive transcription elongation factor b (P-TEFb), which is composed of the kinase CDK9 and its regulatory subunit CCNT1/2. The kinase activity of P-TEFb towards Pol II carboxy-terminal domain (CTD), NELF and DSIF is critical for P-TEFb to execute its function in pause release, and is thus tightly controlled. To date, it has been identified that P-TEFb mainly exists in three different complexes: the super elongation complex (SEC), BRD4-P-TEFb, and the inactive 7SK snRNP-P-TEFb complex. SEC. one of the most active P-TEFb containing complexes, is required for rapid gene expression in response to stress or developmental signals. The active and inactive forms of P-TEFb complexes co-exist in vivo, reaching equilibrium to meet the transcriptional needs of cells. The transition of Pol II from pause to productive elongation stage is achieved by dynamic exchange between the pausing factors and the positive elongation factors at the proximal promoter region. Liquid-liquid phase separation (LLPS) in living cells is a physicochemical process that confines biochemical reactions within membrane-less compartments. Low complexity intrinsically disordered regions (IDRs) within proteins can initiate and promote phase separation and formation of liquid droplets, which in turn facilitate the multivalent weak interactions among these IDR-containing proteins. Recent studies using super-resolution live cell imaging technology have revealed that RNA Pol II can form dynamic foci in cells through LLPS and transitions between different phases, which are likely mediated by phosphorylated CTD. Moreover. factors involved in various transcription steps can rapidly and dynamically concentrate and exchange at the hot regulatory genomic loci. For example, SEC components are able to compartmentalize and concentrate P-TEFb from its inactive partners. Upon serum stimulation. SEC assembles promptly into phase-separated droplets at the immediate early genes (LEG), triggering rapid transcription induction. Mutations in transcription regulators can lead to developmental defects and many human diseases, including cancers. For instance. abnormal stabilization of SEC components via MLL fusion plays a contributing role in leukemogenesis. Fusion of the SEC core component ENL with MLL can greatly enhance phase separation of SEC. through which the leukemic genes might be mis-activated. In addition, there is growing evidence that disease related mutations in transcriptional regulators can cause malfunction through aberrant condensation, providing potential targets for designing therapeutic strategies through phase separation interventions.

Novel insights into RNA polymerase II transcription regulation: transcription factors, phase separation, and their roles in cardiovascular diseases

Phase separation, transcriptional elongation control, and human diseases

Role of transcriptional cofactors in cardiovascular diseases

Phase Separation Properties in Transcriptional Organization

The role of phase separation in RNA modification: both cause and effect

Phase separation of RNA-binding protein promotes polymerase binding and transcription

Coordinating Regulation of Gene Expression in Cardiovascular Disease: Interactions between Chromatin Modifiers and Transcription Factors

Transcriptional regulation of transcriptional Mediator complexes in cardiovascular development and disease.

RNA modification in cardiovascular disease: implications for therapeutic interventions

Phase Separation of Epigenetic Landscape in Cardiovascular Diseases

Dynamic Regulation of Promoter-Proximal RNA Polymerase II Pausing

Mediator and RNA polymerase II clusters associate in transcription-dependent condensates

Regulation of RNA Polymerase II Transcription Initiation and Elongation by Transcription Factor TFII-I

The regulation of circRNA and lncRNA protein binding in cardiovascular diseases: Emerging therapeutic targets

RNA modifications in cardiovascular diseases, the potential therapeutic targets

The role of transcription factors in the pathogenesis and therapeutic targeting of vascular diseases

Non-coding RNAs as Epigenetic Gene Regulators in Cardiovascular Diseases

RNA-binding proteins in cardiovascular biology and disease: the beat goes on

Transcriptional condensates and phase separation: condensing information across scales and mechanisms

Regulatory Effects of Cotranscriptional RNA Structure Formation and Transitions

Emerging roles of phase separation in plant transcription and chromatin organization